These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11102685)
21. Use of hydroxypropyl methylcellulose acetate succinate in an enteric polymer matrix to design controlled-release tablets of amoxicillin trihydrate. Hilton AK; Deasy PB J Pharm Sci; 1993 Jul; 82(7):737-43. PubMed ID: 8360849 [TBL] [Abstract][Full Text] [Related]
22. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles. Park JS; Shim JY; Park JS; Choi YW; Jeong SH Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708 [TBL] [Abstract][Full Text] [Related]
23. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712 [TBL] [Abstract][Full Text] [Related]
25. A unified multicomponent stress-diffusion model of drug release from non-biodegradable polymeric matrix tablets. Salehi A; Zhao J; Cabelka TD; Larson RG J Control Release; 2016 Feb; 224():43-58. PubMed ID: 26763374 [TBL] [Abstract][Full Text] [Related]
26. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up]. Wang MY; Yang YP; Chang JB; Guo MT Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585 [TBL] [Abstract][Full Text] [Related]
27. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer. Gonzalez YM; Ghaly ES Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067 [TBL] [Abstract][Full Text] [Related]
28. Interpolymer Complexation Between Polyox and Carbopol, and Its Effect on Drug Release From Matrix Tablets. Zhang F; Lubach J; Na W; Momin S J Pharm Sci; 2016 Aug; 105(8):2386-96. PubMed ID: 27353208 [TBL] [Abstract][Full Text] [Related]
29. An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. Fukui E; Miyamura N; Kobayashi M J Control Release; 2001 Jan; 70(1-2):97-107. PubMed ID: 11166411 [TBL] [Abstract][Full Text] [Related]
30. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance. Panda B; Subhadarsini R; Mallick S Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690 [TBL] [Abstract][Full Text] [Related]
31. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro]. Li FQ; Hu JH Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886 [TBL] [Abstract][Full Text] [Related]
32. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302 [TBL] [Abstract][Full Text] [Related]
33. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Yamashita H; Sun CC Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440 [TBL] [Abstract][Full Text] [Related]
34. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Krishnaiah YS; Karthikeyan RS; Satyanarayana V Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863 [TBL] [Abstract][Full Text] [Related]
35. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Ravi PR; Ganga S; Saha RN Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Al-Zoubi NM; AlKhatib HS; Obeidat WM Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372 [TBL] [Abstract][Full Text] [Related]
37. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. Ju RT; Nixon PR; Patel MV J Pharm Sci; 1995 Dec; 84(12):1455-63. PubMed ID: 8748329 [TBL] [Abstract][Full Text] [Related]
38. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics. Marinich JA; Ferrero C; Jiménez-Castellanos MR Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Shoaib MH; Tazeen J; Merchant HA; Yousuf RI Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122 [TBL] [Abstract][Full Text] [Related]
40. Predictability of drug release from water-insoluble polymeric matrix tablets. Grund J; Körber M; Bodmeier R Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):650-5. PubMed ID: 23985775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]